Dr. Brett Gregory Aplin, MD

Dr. Aplin practices at Promedica Physicians Pediatric Endocrinology, a Department of Promedica Toledo Hospital - HOPD in Toledo, Ohio.

Dr. Aplin's NPI, 1215164959, was assigned on June 21, 2009. Dr. Aplin graduated from University of Toledo College of Medicine in 2009. Dr. Aplin holds Ohio license 35137630.

Dr. Aplin's primary practice is Promedica Physicians Pediatric Endocrinology, a Department of Promedica Toledo Hospital - HOPD, at 2100 W Central Ave, Toledo, OH 43606.

Dr. Aplin's primary practice is Promedica Physicians Pediatric Endocrinology, a Department of Promedica Toledo Hospital - HOPD in Toledo, Ohio. Dr. Aplin is also affiliated with ProMedica Toledo Hospital. The medical group on file is ProMedica Physicians. Dmand AI also links Dr. Aplin to 4 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Aplin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aplin practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Aplin's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Aplin's licenses on file in 3 states: Ohio, Michigan and Minnesota.

CMS data shows 1,467 Medicare services from Dr. Aplin across 20 procedure codes in 2024, for 1,163 Medicare patients. Medicare paid $66,008 for them.

CMS counts 1,163 Medicare patients who saw Dr. Aplin in 2024. The largest group is 65 to 74, with 521 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aplin's median patient age at 72, with 48% women.

In 2024, Dr. Aplin wrote 431 Medicare Part D claims for 155 patients. 70% of them were for generic drugs. CMS names the drug for 358 of them, across 6 drugs with 11 or more claims each, at $103,037 in total drug cost. In 2023, CMS named 274 claims across 7 drugs.

Dr. Aplin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of leg revascularization (restoring blood flow) by Dr. Aplin, more than 74% of the clinicians it reports for that procedure.

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Aplin, published from 2014 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Prosthesis Design. Dr. Aplin has published most often in Ann Vasc Surg. Dr. Aplin's most frequent co-authors are Jihad T. Abbas, MD, Claudiu Alin Georgescu, MD and Peter Kerr Henke, MD.

CMS Open Payments shows 277 general payments to Dr. Aplin from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Medtronic Vascular, Inc. paid the most, $10,210.

Dr. Aplin graduated from University of Toledo College of Medicine in 2009.